Aspen notes results of Covid-19 trial using a drug it has rights to
The drug maker has rights to dexamethasone, with preliminary results of a trial in the UK showing it can be life-saving for some Covid-19 patients
Drug maker Aspen Pharmacare said on Wednesday it had noted media reports regarding a Covid-19 trial using dexamethasone, a drug it has rights to.
The World Health Organisation (WHO) said on Tuesday a trial had shown that dexamethasone, a corticosteroid, could be life-saving for patients who were critically ill with Covid-19. ..